Adaptive Manufacturing in European Pharma: A Competitive Strategy
To maintain competitiveness in pharmaceutical production, Europe is shifting towards adaptive manufacturing. This approach allows for the flexible production of various drug types, crucial for addressing shortages of essential medications.
Theia Market Signal Identification - AI Assisted
Europe faces challenges in pharmaceutical production due to cost-effective manufacturing in Asia, leading to shortages of essential drugs. The Critical Medicines Act (CMA) aims to enhance local production of critical medicines and active ingredients.
Adaptive manufacturing presents a solution by replacing rigid high-performance lines with flexible production systems, accommodating smaller batch sizes and diverse product variants. Despite advancements in automation enhancing speed and efficiency, traditional systems require significant evolution to meet increasing cost and efficiency pressures. ABB's Machine Automation Division highlights how adaptive manufacturing can offer competitive advantages for European pharmaceutical manufacturers.
Comments